title: UVA1 phototherapy: a concise and practical review.
abstract: High intensity long-wavelength ultraviolet A (340-400 nm; UVA1) lamps were initially developed as skin research tools; over time they have proven to be useful for treating a number of chronic dermatoses. UVA1 units and dosimetry are strikingly different from conventional UV phototherapy. The therapeutic effect of UVA1 is related to the fact that its long wavelength penetrates the dermis more deeply than UVB. UVA1 radiation induces collagenase (matrix metalloproteinase-1) expression, T-cell apoptosis, and depletes Langerhans and mast cells in the dermis. UVA1 exposure stimulates endothelial cells to undergo neovascularization. Ultraviolet A1 exerts significant therapeutic effects in atopic dermatitis and morphea; there is also evidence for its use in other skin diseases, including cutaneous T-cell lymphoma and mastocytosis.
authors.affiliation: Psoriasis and Phototherapy Clinic, Vancouver General Hospital, Vancouver, BC, Canada.
authors.forename: Soodabeh
authors.initials: S
authors.lastname: Zandi
authors.forename: Sunil
authors.initials: S
authors.lastname: Kalia
authors.forename: Harvey
authors.initials: H
authors.lastname: Lui
mesh_terms: D006801:Humans; D018919:Neovascularization, Physiologic / Q000528:radiation effects; D011879:Radiotherapy Dosage; D012867:Skin / Q000378:metabolism / Q000473:pathology / Q000528:radiation effects*; D012871:Skin Diseases / Q000473:pathology / Q000532:radiotherapy*; D014467:Ultraviolet Therapy / Q000379:methods*